Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood protein shots may boost hair growth in balding men

NCT ID NCT07551271

First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 12 times

Summary

This study tested whether injecting platelet-rich plasma (PRP) into the scalp, along with using minoxidil lotion, can improve hair growth in people with moderate to severe androgenetic alopecia (common baldness). Thirty participants were split into two groups: one received PRP injections plus minoxidil, the other minoxidil alone. Researchers measured hair amount and follicle density using a dermoscope and MRI.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • the First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215300, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

platelet-rich plasma (PRP) combined with minoxidil

What this could lead to

If it works, this could offer a more effective way to regrow hair for people with common baldness.

What could go wrong

This is a small, completed study with only 30 participants. Results may not apply to everyone, and PRP requires repeated injections.

Conditions

The condition(s) this trial relates to.

alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.